Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. (Q51923937)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2005

edit

Language	Label	Description	Also known as
English	Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.	scientific article published in December 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

title

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

main subject

phase III clinical trial

0 references

patient

1 reference

based on heuristic

inferred from title

author

Andrew Y. Finlay

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

Christopher Griffiths

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

author name string

Krueger GG

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

Langley RG

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

Woolley JM

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

Lalla D

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

Jahreis A

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

language of work or name

English

0 references

publication date

1 December 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

published in

British Journal of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

volume

153

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

page(s)

1192-1199

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

cites work

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

Physical and psychologic measures are necessary to assess overall psoriasis severity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

10 years experience of the Dermatology Life Quality Index (DLQI).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06948.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2133.2005.06948.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

PubMed publication ID

16307657

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16307657

retrieved

17 April 2018

reference URL

http://europepmc.org/abstract/MED/16307657

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51923937&oldid=1097854325"